Dexcom Study Shows CGM Benefits for Diabetes Patients Not Using Insulin
Dexcom CEO Jake Leach believes the findings could help establish CGM as a standard of care for type 2 diabetes patients who are not on insulin.
Dexcom CEO Jake Leach believes the findings could help establish CGM as a standard of care for type 2 diabetes patients who are not on insulin.
In addition to weight loss, women taking Foundayo also experienced notable reductions in waist circumference, suggesting reduced abdominal fat and cardiometabolic risk, according to Eli Lilly.
Retia Medical expands partnership with Medtronic to distribute its hemodynamic system, Argos Cardiac Output Monitor, in Western Europe.
Unlike conventional immune support products that focus mainly on seasonal wellness, SynbioTech’s newly launched probiotic is designed to support healthy immune ageing.
Novo Nordisk plans to begin a phase 3 development programme for zenagamtide in adults with type 2 diabetes during the second half of 2026.
Let’s explore how robotic surgery is evolving in India with Dr. Sudhir Srivastava, Chairman and CEO of SS Innovations.
The acquisition strengthens Photocure’s bladder cancer diagnostics portfolio by adding Vesica Health’s urine-based molecular diagnostic technology – AssureMDx.
Mabwell said the NMPA has also accepted clinical trial applications for its antibody drug candidate, 9MW5211, in multiple sclerosis.
The record-breaking 20,000-km robotic cardiac telesurgery was performed remotely between Georgetown Public Hospital in Guyana and IRCAD India in Indore by Dr. Sudhir Srivastava using the SSI Mantra Surgical Robotic System.
Dr. Syed Md. Ghouse of AINU performed what is being described as a world-first tele-robotic ureteric reimplantation from Wuhan on a patient in Hyderabad, nearly 3,900 km away.